Tracells

Tracells Overview

Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers. Their stool tests utilize RNA profiles from intestinal cells to accurately diagnose IBD, assess inflammation severity and location, and predict therapy response. This method aims to replace invasive procedures like endoscopies with a convenient, home-based testing alternative, offering precise, cost-effective monitoring and disease management.

Cumulative Funding Raised Over Time ($)

Latest News

Mar 8, 2024 · kalkinemedia.com

Not applicable

Tracells Emerges as a Pioneer in Gastrointestinal Diagnostics and Therapeutics

The article does not provide any specific information about a company, its operations, or any events or changes related to it. The text is largely composed of standard placeholder text (Lorem Ipsum) and does not contain any real content or context. There is a mention of non-invasive stool tests and IBD diagnostics, but no company or specific product is identified.

Not applicable

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Yokne'am Illit, Israel

Photos & Videos

No files yet

Tracells Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info